US FDA approves Hikma's generic version of Novo's diabetes drug Victoza
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
MedPage Today3d
First Generic of Once-Daily GLP-1 Injection Approved for Diabetes
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...
Ohsonline.com2d
NIOSH Updates Hazardous Drug List for Healthcare Workers
NIOSH has released an updated list of hazardous drugs for healthcare workers, incorporating 25 new drugs and removing seven.
USA Today3d
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
Neither drug is considered as effective as the brand ... requiring treatment for type 2 diabetes," Cody Stanford said. The list price for Ozempic and Mounjaro each run more than $1,000 a month ...
New York Post3d
FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza
Diabetes drug Victoza, or liraglutide, is a first generation GLP-1, a class of treatments that has seen overwhelming demand. It has been on the FDA’s shortage list since 2023, and currently ...